fig12

Integrated multi-omics profiling of immune microenvironment and drug resistance signatures for precision prognosis in prostate cancer

Figure 12. Comparison of PCa cell lines with BPH-1 cells, with 3 biological replicates. (A) qRT-PCR detection of differential expression of 10 genes between different groups; (B) Molecules detected as positive in qRT-PCR, subsequently tested using WB; (C) Quantify the blots from 3 replicates comparing the protein levels between different groups. PCa: Prostate cancer; qRT-PCR: real-time quantitative polymerase chain reaction; WB: Western blot. *P < 0.05, **P < 0.01, ***P < 0.001.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/